BlackRock Investment Management, LLC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 42 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2016$1,638,000
-2.6%
1,417,000
-0.1%
0.00%0.0%
Q1 2016$1,682,000
-11.1%
1,419,000
+0.1%
0.00%0.0%
Q4 2015$1,893,000
-0.6%
1,417,0000.0%0.00%
-33.3%
Q3 2015$1,904,000
-15.6%
1,417,0000.0%0.00%0.0%
Q2 2015$2,257,000
+5.2%
1,417,0000.0%0.00%0.0%
Q1 2015$2,146,000
+43.8%
1,417,000
+16.4%
0.00%
+50.0%
Q4 2014$1,492,000
+25.4%
1,217,000
+12.0%
0.00%0.0%
Q3 2014$1,190,000
-2.5%
1,087,000
-6.1%
0.00%0.0%
Q2 2014$1,220,000
+19.7%
1,158,000
+26.1%
0.00%
+100.0%
Q1 2014$1,019,000
+15.1%
918,000
+10.9%
0.00%0.0%
Q4 2013$885,000828,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q2 2015
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 6,195,000$9,377,0002.84%
GUARDIAN LIFE INSURANCE CO OF AMERICA 8,000,000$10,750,0001.09%
Man Investments (CH) AG 1,100,000$1,482,0000.73%
ADVENT CAPITAL MANAGEMENT /DE/ 22,554,000$30,444,0000.47%
SSI INVESTMENT MANAGEMENT LLC 3,124,000$4,202,0000.45%
ARROWGRASS CAPITAL PARTNERS (US) LP 20,000$22,373,0000.42%
Calamos Advisors LLC 35,219,000$47,628,0000.33%
LINDEN ADVISORS LP 2,500,000$3,370,0000.23%
Calamos Wealth Management LLC 513,000$694,0000.17%
LOOMIS SAYLES & CO L P 477,810$50,323,0000.15%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders